Soleno Therapeutics Inc. buy Wells Fargo & Company
Start price
20.08.25
/
50%
€57.65
Target price
20.08.26
€105.76
Performance (%)
-21.94%
Price
28.04.26
€44.60
Summary
This prediction is currently active. The prediction for Soleno Therapeutics Inc. disappoints with a performance of -21.94%. This prediction currently runs until 20.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | -0.402% | -0.402% |
| iShares Core DAX® | -0.372% | 8.404% |
| iShares Nasdaq 100 | 2.269% | 15.232% |
| iShares Nikkei 225® | 1.433% | 14.424% |
| iShares S&P 500 | 1.216% | 10.492% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $123.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€32.80
27.02.26
27.02.26
€93.24
27.02.27
27.02.27
37.20%
28.04.26
28.04.26
